BDX — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

4.04

Margin Of Safety %

Put/Call OI Ratio

0.55

EPS Next Q Diff

1.73

EPS Last/This Y

6.63

EPS This/Next Y

1.06

Price

154.44

Target Price

191.2

Analyst Recom

2.33

Performance Q

0.25

Upside

-12.9%

Beta

0.3

Ticker: BDX

16 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	BDX	176.52	0.52	0.32	15919
2026-03-04	BDX	171.44	0.52	0.50	16172
2026-03-05	BDX	169.92	0.53	0.34	16252
2026-03-09	BDX	165.43	0.53	0.42	16345
2026-03-10	BDX	163.95	0.54	0.16	16299
2026-03-11	BDX	163.26	0.54	1.84	16251
2026-03-12	BDX	159.69	0.54	1.05	16284
2026-03-17	BDX	161.72	0.52	0.74	16511
2026-03-18	BDX	158.06	0.52	1.77	16498
2026-03-19	BDX	156.55	0.51	0.73	16411
2026-03-20	BDX	154.26	0.50	0.09	16361
2026-03-23	BDX	156.17	0.59	0.33	10235
2026-03-24	BDX	155.96	0.57	1.32	10630
2026-03-25	BDX	158.28	0.57	0.10	10735
2026-03-26	BDX	157.36	0.56	0.08	10867
2026-03-27	BDX	154.45	0.55	1.31	11038
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

16 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-02-27	BDX	176.44	-17.1	243.7	12.54
2026-03-02	BDX	176.56	-17.1	-530.3	12.54
2026-03-03	BDX	174.24	-17.1	-550.5	12.54
2026-03-04	BDX	171.47	-17.1	-554.4	12.54
2026-03-05	BDX	169.91	-17.1	-544.6	12.54
2026-03-06	BDX	167.21	-17.1	-554.5	12.54
2026-03-09	BDX	165.46	-17.1	-545.5	12.54
2026-03-10	BDX	163.91	-17.1	-535.5	12.54
2026-03-11	BDX	163.21	-17.1	-527.7	12.54
2026-03-12	BDX	159.66	-17.1	-553.2	12.54
2026-03-13	BDX	159.40	-17.1	-523.9	12.54
2026-03-17	BDX	161.74	-17.1	-508.4	12.54
2026-03-18	BDX	158.08	-17.1	-554.0	12.54
2026-03-19	BDX	156.53	-17.1	-536.1	12.54
2026-03-20	BDX	154.20	-17.1	-543.5	12.54
2026-03-23	BDX	156.19	-17.1	-502.6	12.54
2026-03-24	BDX	155.92	-17.1	-524.7	12.54
2026-03-25	BDX	158.25	-17.1	-500.2	12.54
2026-03-26	BDX	157.37	-17.1	-530.0	12.46
2026-03-27	BDX	154.44	-17.1	-548.9	12.46
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-02-27	BDX	-0.85	-4.14	5.12
2026-03-02	BDX	-0.87	1.90	5.12
2026-03-03	BDX	-0.87	1.90	5.12
2026-03-04	BDX	-0.87	1.90	5.12
2026-03-05	BDX	-0.87	1.90	5.12
2026-03-06	BDX	-0.87	1.90	5.12
2026-03-09	BDX	-0.87	1.87	5.12
2026-03-10	BDX	-0.87	1.87	5.12
2026-03-11	BDX	-0.87	1.87	4.85
2026-03-12	BDX	-0.70	1.87	4.85
2026-03-13	BDX	-0.70	1.87	4.85
2026-03-17	BDX	-0.70	2.03	4.85
2026-03-18	BDX	-0.70	2.03	4.85
2026-03-19	BDX	-0.70	2.03	4.85
2026-03-20	BDX	-0.70	2.03	4.85
2026-03-23	BDX	-0.70	2.01	4.85
2026-03-24	BDX	-0.70	2.01	4.85
2026-03-25	BDX	-0.70	2.01	4.04
2026-03-26	BDX	-0.70	2.01	4.04
2026-03-27	BDX	-0.72	2.01	4.04
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

1.34

Avg. EPS Est. Current Quarter

2.78

Avg. EPS Est. Next Quarter

3.07

Insider Transactions

-0.72

Institutional Transactions

2.01

Beta

0.3

Average Sales Estimate Current Quarter

4666

Average Sales Estimate Next Quarter

4911

Fair Value

165.84

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

31.7

Max Drawdown 5-Year %

-39.6

Target Price

191.2

P/E

25.24

Forward P/E

11.48

PEG

1.42

P/S

2.01

P/B

1.74

P/Free Cash Flow

16.72

EPS

6.12

Average EPS Est. Cur. Y

12.46

EPS Next Y. (Est.)

13.51

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

8.01

Relative Volume

0.74

Return on Equity vs Sector %

-20.4

Return on Equity vs Industry %

-2.6

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.08

EBIT Estimation

-548.9

◆ BDX Healthcare

$154.51

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

16/20

Pullback

19/25

Volume

9/15

Valuation

18/20

TP/AR

1/10

Options

3/10

RSI

33.7

Range 1M

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

14/25

Growth

14/30

Estimates

4/20

Inst/Vol

5/15

Options

5/10

EPS Yr

10.7%

EPS NY

7.4%

52W%

46.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +53.1% upside

Quality

7/30

Valuation

17/30

Growth

12/25

Stability

5/10

LT Trend

1/5

Upside

+53.1%

Quality

MoS

Becton, Dickinson and Company

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 70000

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

BDX

Latest News

—

Caricamento notizie per BDX…

stock quote shares BDX – Becton, Dickinson and Company Stock Price stock today

news today BDX – Becton, Dickinson and Company stock forecast ,stock prediction 2023 2024 2025

marketwatch BDX – Becton, Dickinson and Company yahoo finance google finance

stock history BDX – Becton, Dickinson and Company invest stock market

stock prices BDX premarket after hours

ticker BDX fair value insiders trading

BDX – Becton, Dickinson and Company

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: BDX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y